GOEL DAVID E. — SEC Form 4 filings
SEC reporting owner CIK 1548144. 5 Form 4 filings on record with FilingPulse; latest filed 2026-05-11.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-07-03 to 2026-05-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 14,422,870 shares, $49,019,987 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 6,922,870 shares @ $5.64 ($39,044,987) in Aura Biosciences, Inc., filed 2026-05-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aura Biosciences, Inc. (AURA) | 10% owner | 1 | — | 1 leg · 6,922,870 sh · $39,044,987 | — |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | 10% owner | 1 | — | 1 leg · 7,500,000 sh · $9,975,000 | — |
| ALUMIS INC. (ALMS) | Director, 10% owner | 2 | — | — | 6 |
| ACELYRIN, Inc. (SLRN) | Director, 10% owner | 1 | — | — | 1 |
Form 4 filings — GOEL DAVID E.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-11 | 4 | Aura Biosciences, Inc. (AURA) jointly with Matrix Capital Management Company, LP | Sale (S): 6,922,870 @ $5.64 | EDGAR |
| 2025-12-15 | 4 | Zentalis Pharmaceuticals, Inc. (ZNTL) jointly with Matrix Capital Management Company, LP | Sale (S): 7,500,000 @ $1.33 | EDGAR |
| 2025-05-23 | 4 | ALUMIS INC. (ALMS) jointly with AyurMaya Capital Management Company, LP | Grant/award (A): 4,493,741 | EDGAR |
| 2025-05-23 | 4 | ACELYRIN, Inc. (SLRN) jointly with AyurMaya Capital Management Company, LP | Disposition to issuer (D): 9,334,735 @ $0 | EDGAR |
| 2024-07-03 | 4 | ALUMIS INC. (NASDAQ) jointly with AyurMaya Capital Management Company, LP | Conversion (C): 8,145,966 · Grant/award (A): 2,500,000 @ $16 · Conversion (C): 20,000,000 (derivative) @ $0 · Conversion (C): 5,336,489 (derivative) @ $0 · Conversion (C): 12,745,916 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1548144 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →